Letter to Editor

The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence

Volume: 1 Number: 1 October 10, 2024
TR EN

The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence

Abstract

The field of drug discovery is undergoing transformative changes driven by technological advancements and a deeper understanding of biological systems. This editorial discusses the future directions and potential of innovative drug discovery, emphasizing the need for strategic approaches amidst economic constraints and industry-academia collaboration challenges. Key topics include the importance of affordable, effective drugs with minimal side effects, the role of computer-based methods like molecular docking and QSAR, and the impact of big data and artificial intelligence in accelerating drug development processes. Highlighting dual-target compounds, the editorial explores their potential in treating complex diseases by targeting multiple biological pathways. The integration of AI and dual-target strategies promises significant advancements in drug discovery, offering new avenues for effective and safer therapies.

Keywords

References

  1. Guo, Y., Zou, Y., Chen, Y., Deng, D., Zhang, Z., Liu, K., Tang, M., Yang, T., Fu, S., Zhang, C., Si, W., Ma, Z., Zhang, S., Peng, B., Xu, D., & Chen, L. (2023). Design, synthesis and biological evaluation of purine-based derivatives as novel JAK2/BRD4 (BD2) dual target inhibitors. Bioorganic Chemistry, 132, 106386.
  2. Masson, P., & Mukhametgalieva, A. R. (2023). Partial Reversible Inhibition of Enzymes and Its Metabolic and Pharmaco-Toxicological Implications. International Journal of Molecular Sciences, 24(16), 12973.

Details

Primary Language

English

Subjects

Pharmaceutical Chemistry

Journal Section

Letter to Editor

Publication Date

October 10, 2024

Submission Date

August 6, 2024

Acceptance Date

August 15, 2024

Published in Issue

Year 2024 Volume: 1 Number: 1

APA
Yücel, M. A., & Algül, Ö. (2024). The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 1(1), 1-3. https://izlik.org/JA57WG63DM
AMA
1.Yücel MA, Algül Ö. The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. Journal of Health Sciences Institute. 2024;1(1):1-3. https://izlik.org/JA57WG63DM
Chicago
Yücel, Mehmet Ali, and Öztekin Algül. 2024. “The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence”. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 1 (1): 1-3. https://izlik.org/JA57WG63DM.
EndNote
Yücel MA, Algül Ö (October 1, 2024) The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 1 1 1–3.
IEEE
[1]M. A. Yücel and Ö. Algül, “The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence”, Journal of Health Sciences Institute, vol. 1, no. 1, pp. 1–3, Oct. 2024, [Online]. Available: https://izlik.org/JA57WG63DM
ISNAD
Yücel, Mehmet Ali - Algül, Öztekin. “The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence”. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 1/1 (October 1, 2024): 1-3. https://izlik.org/JA57WG63DM.
JAMA
1.Yücel MA, Algül Ö. The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. Journal of Health Sciences Institute. 2024;1:1–3.
MLA
Yücel, Mehmet Ali, and Öztekin Algül. “The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence”. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, vol. 1, no. 1, Oct. 2024, pp. 1-3, https://izlik.org/JA57WG63DM.
Vancouver
1.Mehmet Ali Yücel, Öztekin Algül. The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. Journal of Health Sciences Institute [Internet]. 2024 Oct. 1;1(1):1-3. Available from: https://izlik.org/JA57WG63DM